natgillin/translations-raw huggingface dataset:
The industry was caught in a crisis in one moment, not because of the fall in quality of products or because of inconsistency in the technological development, but because of innovations that appeared on the market. 
Tu je industriju u jednom trenutku zadesila kriza ne zbog pada kvalitete proizvoda ili nedosljednosti u tehnološkom razvoju već zbog inovacija koje su se pojavile na tržištu.
The product offered met a great challenge. 
Proizvod koji su nudili susreo se sa velikim izazovom.
To maintaining the quality and to turn around the production in most cities in completely new directions. Even a layman can see in his own eyes that German vehicles are still largely present on the roads which means they have succeeded! 
Održati kvalitetu, a proizvodnju u većini grana zaokrenuti u potpuno novim smjerovima.I laik može zaključiti na temelju promatranja da Njemačka vozila i dalje u velikom broju voze cestama što znači da su uspjeli!
The change of attitudes of the participants in the process of creation brought progress and development. 
Promjena stavova sudionika u procesu stvaranja donijela je napredak i razvoj.
If we compare it to other car industries in the world, we can say that all the systems that obeyed the tested principles, failed. 
Usporedimo li to sa drugim auto industrijama u svijetu možemo reći da svi sustavi koji su se konzervativno držali isprobanih načela, nisu uspjeli.
Innovation on the basis of tradition is surely a subject that must be carefully installed into every development system, and ours as well. 
Inovacija na temeljima tradicije zasigurno je tema koja se mora pomno ugraditi u svaki razvojni sustav pa tako i naš.
Analysis of the McGill University from Quebec in Canada processed an intriguingly applied area of technology development and learning in the processes of development, which can among other things be applied to economy. 
U analizi McGill University iz Quebeca u Kanadi obrađeno je zanimljivo primjenjeno područje razvoja tehnologije i učenja u procesima razvoja koji se između ostaloga mogu primjeniti i na gospodarstvo.
Once again, we come across the thesis according to which a man is a measure of all things in the system he created and in the ecosystem he adjusted to himself and his living habits. 
Ponovno nailazimo na tezu prema kojoj je čovjek mjerilo svega u sustavu koji je kreirao i ekosistemu koji je prilagodio sebi i svojim životnim navikama.
Even in this most simple presumption, there is a talk of adjusting the "living environment of ancestors" to the new inheritances and development, but where it is "foundations upon which further building is done are slowed down"(Clark, Kok, Lacroix, 1999). 
Čak u toj najjednostavnijoj postavci govori se o prilagođavanju „životne sredine predaka“ novim tekovinama i razvoju ali gdje se „zadržavaju osnove na temelju kojih se gradi dalje“ (Clark, Kok, Lacroix, 1999).
If we look at it from the nature's point of view, numerous new possibilities open up to us. 
Sagledamo li to sa gledišta prirode otvaraju nam se mnoge nove mogućnosti.
So far, in the development of economy based on exploitation of mines and exploitation in general, there wasn't much care given to the use and to the creation of renewable resources. 
Do sada se u razvoju gospodarstva temeljenog na eksploataciji rudnih bogatstava i eksploataciji općenito nije mnogo marilo za ne samo korištenje već i kreiranje obnovljivih izvora resursa.
Whether it is about energy of raw materials necessary for construction and life, there is an awareness of the need for sources that won't "dry out". 
Bilo da se govori o energiji ili sirovinama potrebnima za gradnju i život budi se svijest o potrebi za izvorima koji su „nepresušni“.
Some will say that such positioning of things is not possible and that the perpetuum mobile is a long gone fantasy. 
Neki će reći da tako postavljanje stvari nije moguće i da je perpetum mobile odavno napuštena fantazija.
This process of consolidation of development and efficient management of environment is possible only if the information on the need and effort is consolidated with the information quickly and efficiently enough with the possibilities and compatibilities of the system in which we live and work. 
Taj proces usuglašavanja razvoja i učinkovitog gospodarenja okolišem moguć je jedino ukoliko se informacija o potrebi i nastojanju dovoljno brzo i učinkovito usuglasi sa informacijom, o mogućnostima i kompatibilnostima sistema u kojem živimo i djelujemo.
Science and innovation in the service of environmental protection and sustainable development are the foundation on which we will build modern economic systems. 
Znanost i inovacija u službi zaštite okoliša i održivog razvoja temelj su kojem ćemo graditi moderne sustave gospodarstava.
Bionics (concept which is also known as biomimicry, biomimetics, bio-inspiration, bionic engineering) is the application of biological methods and systems in nature for studying and the system design in modern technology. 
Bionika (pojam također poznat kao biomimikrija, biomimetika, bioinspiracija, bionički inženjering) je primjena bioloških metoda i sustava u prirodi za proučavanje i dizajn sustava u modernoj tehnologiji.
The term bionic was coined by Jack E. 
Riječ bionic je skovao Jack E.
Steele in 1958, and it probably comes from the Greek word βίον, [BI: o], meaning the "unit of life" and suffix -ic meaning "like" or "in the manner of" therefore, "life-like". 
Steele je 1958, vjerojatno potječe od grčke riječi βίον, [BI: o], što znači "jedinicu života" i sufiksa-ic, što znači "kao" ili "u maniri", dakle "kao život".
Actually, bionics largely uses copying of natural principles in everyday technological development (Littvay 2010). 
U biti, velikim dijelom bionika se koristi kopiranjem prirodnih principa u svakodnevnom tehnološkom razvoju (Littvay 2010).
This is the slogan that imposes itself as the creed of modern industrial development. 
Ta parola nameće se kao kredo modernog industrijskog razvoja.
By adjusting the existing industrial systems in a manner that we adopt the biological principle of building, the entire process shall be made more efficient and by that, more cost-effective. 
Prilagođavanjem postojećih industrijskih sistema na način da usvojimo biloški princip gradnje učinit će cijeli proces mnogo učinkovitijim i samim time isplativijim.
We see the wood in our sector mainly as construction material which is either a living organism but we use it exactly as non-living material. 
Mi drvo u našoj grani promatramo uglavnom kao građevno sredstvo koje jest bilo živi organizam ali koristimo ga upravo kao neživi materijal.
If we pay attention to its microstructure through the mechanics of cellular walls, we conclude that it is the peak of technological accomplishment of natural mega building. 
Obratimo li pozornost na njegovu mikrostrukturu kroz mehaniku staničnih stjenki zaključujemo da je to vrhunac tehnološkog ostvarenja prirodne mega gradnje.
If the wood is treated through technological processes of adjusting to our needs and in this time we pay attention to the before mentioned facts, we can acquire super material of high quality from reasonably available source of raw material. 
Ukoliko to drvo tretiramo kroz tehnološke procese prilagođavanja našim potrebama i pritome obratimo pozornost na prije spomenute činjenice možemo dobiti supermaterijal vrhunske kakvoće iz razumno povoljnog izvora sirovine.
The secret of multiplicativeness of wood lies in its microstructures and can help in solving the problems in the macroworld. 
Tajna multiaplikativnosti drva koja leži u njegovim mikrostrukturama može pomoći i rješavanju problema u makro svijetu.
By dividing the wood mass into basic components, we get a series of raw materials from which in the technological processes, we produce everything, from objects to driving energy. 
Rastavljanjem drvne mase na komponente od kojih je sačinjena dobivamo niz sirovina od kojih u tehnološkim procesima proizvodimo sve od predmeta do pokretačke energije.
Composite materials which in their basis contain wood and materials which only mimic the mechanical build of wood cells, definitely present the future of wood industry. 
Kompozitni materijali koji u svojoj osnovi sadrže drvo i materijali koji samo oponašaju mehaničku građu drvnih stanica zasigurno su budućnost drvne industrije.
Bionic principles in the design start just on this macrolevel in order to produce superior product in the end. 
Bionički principi u dizajnu počinju upravo na ovoj mikro razini da bi producirali vrhunski proizvod na kraju.
If we observe the development of material in wood industry, we can see that smaller aggregates of wood particles are being used more often than the whole wood and use of its natural mechanical properties, and these make the modern wood construction materials. 
Ako promatramo razvoj materijala u drvnoj industriji možemo primjetiti da se od cjelovitog drva i korištenja njegovih prirodnih mehaničkih svojstava sve više koriste sitniji i sitniji agregati drvnih čestica koje čine moderne drvne građevne materijale.
By examining the microscopic indicators of results of breaks on the cell xsylem of the coniferous wood S2 layer which is present in cca 
Proučavajući mikroskopske pokazatelje posljedica loma na ksilemu stanica drva četinjača S2 sloja koji je zastupljen cca.
80% in the construction of cell, and is made of cellulose microfibrile measures under 15° to the longitudinal axle of the cell achieves interesting results. 
80% u izgradnji stanice, a načinjen je od celuloznih mikrofibrila usmjerenih pod 15° na uzužnu os stanice ostvaruje zanimljive rezultate.
Engineering analysis of construction units in this structure proves that the wood cell in this manner distributes the force which performs load and thus increases the elastic purposes of the cell itself. 
Inžinjerskom analizom građevnih jedinica u ovoj strukturi dokazano je da stanica drva na taj način distribuira silu koja vrši opterećenje i time povećava elastična svojstva same stanice.
This model is replicated from composite materials according to the same "recipe". 
Ovakav model repliciran je od kompozitnih materijala prema istom „receptu „.
The fibres in this model are placed under the same angle of 15° and during load, they demonstrated better elastic properties than the materials where the fibres were placed in different positions (Vincent 2003). 
Vlakanca su u tom modelu postavljena pod istim kutem od 15° i prilikom opterećenja pokazivala su bolja elastična svojstva od materijala u kojima su vlakanca bila postavljena u drugačiji pozicijama (Vincent 2003).
This proves that the nature doesn't need metal construction in order to produce durable materials but can make high quality and resistance composites from cellulose and lignine. 
Ovo dokazuje da priroda ne treba metalne konstrukcije da bi proizvela durabilne materijale već od celuloze i lignina čini kompozite visoke kakvoće i otpornosti.
Where to now? 
Kamo dalje?
They have to change slowly in the processes of adjustments and modernisation but according to the indicators, there are not threaten by decline or disappearance if changes are to be implemented in quality way. 
Oni se u procesima prilagodbe i modernizacije polako moraju mjenjati ali prema pokazateljima ne prijeti im propadanje ili nestanak ako kvalitetno implementiraju promjene.
More important is maybe the subject of introducing new technologies based on innovations and development of new materials and products. 
Važnija je možda tema uvođenje novih tehnologija zasnovanih na inovacijama i razvoju novih materijala i proizvoda.
In an inability to quality compete with mass produced cheap product from the gigantic markets of China and technology developed western countries, there are only few options left. 
U nemogućnosti da kvalitetno konkuriramo masovno proizvedenom jeftinom proizvodu s gigantskih tržišta Kine i tehnološki razvijenim zapadnim zemaljama ostaje nam malo mogućnosti.
In the perspective, this is not so bad as this simplifies our decision whether to orient oneself to the development of economy or which will service only for the needs of bigger and stronger and to live of the crumbs they reject, or to wisely engage into the clash with the development through own innovation in cooperation with others and to develop a competitive product. 
To u perspektivi i nije tako loše jer nam pojednostavljuje odluku da li se orijentirati na razvoj gospodarstva koje će servisirati samo potrebe većih i jačih i živjeti od mrvica koje oni odbace ili se pametno uhvatiti u koštac s razvojem i kroz vlastitu inovaciju u suradnji sa drugima razvijati konkurentan proizvod.
Organizational unit 
Ustrcjsfrena jedinica
Registration number 
Urudzbeni broj
REPUBLIC OF CROATIA MINISTRY OF HEALTH AND SOCIAL WELFARE 
REPUBLIKA HKVATSKA .34-MINISTARSTVO ZDRAVSTVA I SOCIJALNE SKRBI
Phone: 
Tel:
Ministry of Health and Welfare 
Ministarstvo zdravstva i socijalne skrbi
attn: Romana Katalinic, MD. 
n/r Roman a Katalinic, dr.med.
In Zagreb, 28 September 2011 
U Zagrebu, 28. rujna 2011.
Application for the approval of clinical trial entitled: 
Zamolba za suglasnost provodenja klinickog ispitivanja pod nazivom:
in the Republic of Croatia in which the following centres will participate: 
Hrvatskoj u kojem ce sudjelovati sljedeci centri:
Mira Fingler, MD 
Mira Fingler, dr.med.
Clinical Hospital Centre Osijek, Josipa Huttlera 4, 31 000 Osijek 
KHnicki bolnicki centar Osijek, Josipa Huttlera 4, 31 000 Osijek
Davorka Špičić - Treursic, MD 
Davorka Spisic - Treursic, dr.med.
General Hospital Dr. 
Opca bolnica dr.
Ivo Pedišić, 
Ivo Pedisic,
Ivan Sklebar, MD 
Ivan Sklebar, dr.med.
General Hospital Bjelovar, Mihanovićeva 8, 43 000 Bjelovar 
Opca bolnica Bjelovar, Mihanoviceva 8, 43 000 Bjelovar
The following centres are planned to participate in the trial, for which the approval of the Central Ethics Committee shall be sent upon receipt: 
Pianirano je sudjelovanje i sljedecih centara, za koja ce Vam odobrenje Sredisnjeg etickog povjerenstva biti poslano odmah po primitku:
Name and surname of the principal investigator 
Ime i prezime glavnog ispitivaca
Primarius 
Prim.
Ines Adanic - Mikloška, MD 
Ines Adanic - MikloSka, dr.med.
Clinical Hospital Centre Zagreb, Kišpatićeva 12, 10 000 Zagreb 
KliniCki bolnicki centar Zagreb, Kispaticeva 12, 10 000 Zagreb
We hereby request approval for the aforementioned clinical trial in the Republic of Croatia 
ovim Vas putem molimo za suglasnost za provodenje gore navedenog klinickog ispitivanja u Repubiici
To whom it may concern, 
Postovani,
Commercial Court in Zagreb, MBS080486909, MB 1827413, OIB:09010288617, General Director 
Trgovacki sud u Zagrebu MBS 080486909, MB 1827413, OIB:09010288617, Generalni direktor:
Zagreb, giro account: 
Zagifeb, ziro racun:
Željko Ivanec, MD 
Zeljko Ivanec, dr.med.
Clinical Hospital Centre Sestre milosrdnice, Vinogradska cesta 29, 10 000 Zagreb 
Klinicki bolnicki centar Sestre milosrdnice, Vinogradska cesta 29, 10 000 Zagreb
Vanja Bašić-Kes, MD 
Vanja Basic-Kes, dr.med.
Mira Fingler, MD, shall be national coordinator of the aforementioned clinical trial in the Republic of Croatia. 
Mira Fingler, dr. med., bit ce nacionalni koordinator gore navedenog klinickog ispitivanja u Republici Hrvatskoj.
The clinical trial entitled Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid Induced Constipation (OIC). 
Navedeno klinicko ispitivanje randomizirano, dvostruko slijepo, placebom kontrolirano ispitivanje za procjenu ucinkovitosti i sigurnosti lijeka NKTR-118 u ispitanika koji pate od boll nepovezane s rakom i konstipacije zbog primjene opioidnih lijekova.
The tested drug NKTR-118 is peripherally acting opioid antagonist in development for the treatment of constipation due to use of opioid drugs in patients suffering from pain. 
Ispitivani lijek NKTR-118 je periferno djelujuci opiodni antagonist, koji se razvija za Iije5enje konstipacije zbog primjene opiodnih lijekova u ispitanika koji pate od boli.
NKTR-118 is PEGylated Derivate of Nalaxone developed to to have significantly reduced possibility of penetrating blood-brain barrier. 
NKTR-118 je PEGilirani derivat naloksona osmisljen da ima znacajno smanjenu mogucnost prolaska krvno-mozdane barijere.
Approximately 120 centres and 630 patients worldwide are expected to participate in the trial. 
Planira se da ce u ispitivanje biti ukljuceno oko 120 centara diljem svijeta i da ce u njemu sudjelovati oko 630 ispitanika.
Patients will be given detailed information before the trial and will confirm their participation by signing the informed consent which guarantees anonymity and confidentiality of all medical records. 
Prije samog ispitivanja ispitanici ce dobiti detaljne informacije, a sudjelovanje u klinickom ispitivanju potvrdit ce potpisivanjem informiranog pristanka pri cemu im je osigurana anonimnost i tajnost svih medicinskih podataka.
The treatment will last 18 weeks and include initial screening period in the duration of up to two weeks, two-week period of constipation confirmation due to use of opioid drugs, the twelve-week treatment period and two-week period of controlled visits after the administration of the last dose of the trial drug . 
Lijecenje traje 18 tjedana i sastoji se od pocetnog razdoblja probiranja koje traje do 2 tjedna, dvotjednog razdoblja potvrdivanja konstipacije zbog primjene opioidnih lijekova, razdoblja lijecenja od 12 tjedana i 2 tjedna kontrolnih posjeta nakon posljednje doza ispitivanog lijeka.
In the period up to 3 June 2011, the clinical trial was not rejected in any of the applying countries. 
Zakljucno sa 3. lipnja 2011., provodenje klinickog ispitivanja nije odbijeno niti u jednoj zemlji u kojoj je zahtjev podnesen.
In order to clearly define which group of women, given their age and period elapsed since their last menstruation cycle are considered postmenopausal women, and pursuant to the CEC guidelines, we enclose the letter of the Sponsor, in which it is defined in detail the difference between the protocol and the informed consent for participants. 
U svrhu jasnog definiranja koje se zene obzirom na dob i vrijeme proteklo od zadnje menstruacije smatraju zenama u postmenopauzi i u skladu sa smjernicama SEP-a, prilazemo dopis narucitelja ispitivanja, koji poblize objasnjava razlike izmedu plana ispitivanja i informiranog pristanka za ispitanike.
We hereby wish to inform you that all investigators in the Republic of Croatia shall adhere to the request related to the aforementioned criterion stated in the informed consents, in accordance with the CEC guidelines . 
Ovim Vas putem zelimo obavijestiti da ce se svi ispitivaci u Republici Hrvatskoj pridrzavati zahtjeva vezanih uz spomenuti kriterij navedenih u informiranom pristanku, prema smjernicama SEP-a.
We hereby inform you that the genetic sub-trial shall not be conducted in the Republic of Croatia. 
Ovim Vas putem obavjestavamo da se genetiCko podispitivanje nece provodti u Republici Hrvatskoj,
The enclosed patient documents shall be available at the trial centres elusively to the members of the personnel participating in the trial that shall provide the patients participating or expected to participate in the clinical trial with the documents. 
Prilozeni dokumenti za ispitanike ce na ispitivackim centrima biti dostupni iskljucivo clanovima ispitivackog osoblja, koji ce ih uruciti ispitanicima koji su vec ukljuceni ili za koje se planira ukljucivanje u klinicko ispitivanje.
The list of provided documents and the handing procedure shall be recorded in the original patient documentation, pursuant to the guidelines of the Good Clinical Practice. 
Popis urucenih dokumenata i postupak urucivanja dokumenta ce biti zabiljezen u izvornoj dokumentaciji ispitanika, prema preporukama Dobre klinidke prakse.
Archiving, use and handing of patients documents shall be restricted to the trial centres and medical clinics in which the trial will be conducted. 
Pohrana, upotreba i urucivanje dokumenata za ispitanike bit ce ograniCena na ispitivacke centre i lijecnicke ordinacije u kojima ce se ispitivanje provoditi.
According to the existent regulations, the clinical trial shall not be publicly advertised in media or other public places. 
Prema postojecim propisima, klinicko ispitivanje nece biti javno oglasavano u medijima niti javnim mjestima.
The aforementioned patients documents include key information related to the backgroud, purpose and procedures in the clinical trial, as follows: 
Spomenuti dokumenti za ispitanike sadrze kljucne informacije vezane za pozadinu, svrhu i postupke u klinickom ispitivanju, kako slijedi:
This document is a two-sided cars with patient data on one side and relevant information for investigators on the other. 
Rijec je o dvostranoj kartici s podacima namijenjenim ispitaniku na jednoj strani i odgovarajucim informacijama za ispitivace na drugoj strani.
Patient Leaflet includes an area for a sticker with contact details of the trial centre and the patients can carry them home . It is intended for potential patients. 
Letak za ispitanike sadrzi prostor u kom ce se nalijepiti naljepnica sa kontakt detaljima ispitivadkog centra i ispitanik ju moze ponijeti kuci, a namijenjen je mogucim ispitanicima.
- Guide for Informed Consent is designed to facilitate talks to obtain consent of the potential patients. 
- Vodic za informirani pristanak namijenjen je olaksavanju razgovora radi dobivanja pristanka od mogucih ispitanika.
Physician's Letter to Patient gives a brief overview of the clinical trial and the most important inclusion criteria; it can be sent to the home address of the patients considered for the trial. 
Pismo lijecnika ispitaniku daje kratak pregled ispitivanja i najvaznijih kriterija za ukljucivanje, koje moze biti poslan na kucnu adresu ispitanicima za koje se razmatra mogucnost ukljucivanja u ispitivanje.
Patient Brochure includes a brief trial overview. 
Brosura za ispitanike sadrzi sazet pregled ispitivanja.
It is intended for patients considered for the clinical trial and their families. 
Namijenjena je ispitanicima za koje se razmatra ukljucivanje u ispitivanje i njihovim obiteljima.
It can also be used by the members investigation teams to explain the goals and procedures during the clinical trial. 
Mogu ju upotrijebiti i clanovi ispitivackim timova prilikom objaSnjavanja ispitanicima ciljeva i postupaka tijekom klinickog ispitivanja.
Patient Poster states the goals of the clinical trial and inclusion criteria; it will be hang only at the trial centre and the medical clinic participating in the trial. 
Plakat za ispitanike navodi ciljeve klinickog ispitivanja i kriterije za ukljucivanje, a bit ce izvjesen iskljucivo u ispitivackom centru i lijecnickoj ordinaciji u kojoj ce se ispitivanje provoditi.
Patient Identity Card confirms that that the patient is participating in the clinical trial and includes trial centre contact information in case of medical emergencies. 
Iskaznica ispitanika potvrduje daje ispitanik ukljucen u navedeno klinicko ispitivanje i sadrzi kontaktne detalje ispitivackog centra za slucajeve hitne medicinske intervencije.
Patient guide is indented for patients included in the trial, and includes a detailed description of the trial and trial procedures per specific visits, patient's obligations during participation in the trial, including information that the patient will enter into the patient eDiary. 
Vodic za ispitanike namijenjen je ispitanicima ukljucenima u ispitivanje, a pruza detaljniji opis ispitivanja i postupaka u ispitivanju prema pojedinacnim posjetima, obaveze ispitanika prilikom sudjelovanja u ispitivanju, ukljucujuci i podatke koje ce ispitanik unositi u elektronicki dnevnik.
The Patient Calendar and Visit Reminder are intended fro patients included in the trial and enable the patients to enter relevant dates of visits to the trial centre. 
Kalendar za ispitanike i podsjetnik za posjete namijenjeni su ispitanicima ukljucenima u ispitivanje, a ispitanicima omogucuju unoSenje odgovarajucih datuma posjeta ispitivackom centru.